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Abstract
The physiological function of intracellular calcium oscillations has eluded
investigators. Given that calcium plays an important role in many signal
transduction processes and that the frequency of oscillations can be controlled by
external agonists, the biorhythmic phenomena may represent a type of frequency-
encoded information train. In this thesis, I propose that calcium-activated, enzyme
systems may act as a biomolecular "decoder" of these calcium signals. First,
computer models were employed to demonstrate that a frequency-
encoding/decoding paradigm is feasible at physiologically-relevant conditions.
Then, several hardware/firmware implementations were constructed to generate
artificial, calcium oscillations for in vitro study. Next, experiments were
conducted with three calcium-activated, enzyme systems: phospholipase A-,
calpain, and calcineurin. Finally, analytical software was developed to scrutinize
empirical results for frequency-dependency and to account for variability in the
artificially-generated, calcium oscillations.
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Chapter 1
Introduction
Intracellular calcium oscillations are known to occur in a variety of cells [5,10,22].
The function of this biorhythmic phenomena is still unclear. Given that calcium
plays an important role in many signal transduction processes and that the
frequency of oscillations can be controlled by external agonists, these oscillations
may represent a type of frequency-encoded information train.
The time and spatial variance of Ca2+ waves potentially contain much
more information than simple static levels of intracellular Ca2+ [5].
Calcium-activated, enzyme systems may perform as a type of biomolecular
"decoder" of these calcium signals. In the case where the period of oscillation is
short compared to the time scale of protein deactivation, the repetitive calcium
peaks may yield an additive effect, elevating apparent enzyme activity. This may
explain why in vitro assays of some enzymes, such as calpain type I, curiously
require millimolar calcium concentrations to obtain the same activity achievable
with micromolar calcium concentrations in vivo [45].
Furthermore, different enzyme systems have widely varying calcium
requirements and activation/deactivation characteristics. This suggests that each
protein is likely to have an unique response to the frequency of calcium
oscillations. In this context, calcium oscillations could represent a versatile,
intracellular signal with the ability to "turn on" a particular enzyme system without
disturbing others. Though similar selective control is also conceptually possible
with the traditional, static model, many additional cofactory and inhibitory
"signals" would be required. Such inefficient use of bandwidth is unattractive
from both an engineering perspective and from a biological/evolutionary
standpoint.
This thesis explores a frequency-domain encoding/decoding paradigm.
First, computer models were employed to show that frequency-encoding is feasible
at physiologically-relevant conditions. Moreover, simulations demonstrate that
two enzymes can decode the same calcium oscillations in an interesting and
biologically meaningful manner.
Then, several hardware/firmware implementations were constructed to
generate artificial, calcium oscillations for in vitro study. The prototype used in
the investigation alternately released small volumes of calcium solution and EGTA
(calcium chelator) solution into assay buffer. Periodical delivery via miniature
solenoid valves was synchronized with a programmable microcontroller designed
for this task. Calcium concentration was continuously monitored using molecular
probes and a fluorescent instrument.
Next, experiments were conducted with three calcium-activated, enzyme
systems: phospholipase A2 (PLA 2), calpain type I (a protease), and calcineurin (a
phosphatase). Techniques of molecular biology were necessary for the
manufacturing of a radioactively-labeled GST-fusion protein to assay calcineurin
activity. Finally, analytical software was developed to scrutinize empirical results
for frequency-dependency and to account for variability in the artificially-
generated calcium oscillations.
Chapter 2
Background
2.1 Intracellular Calcium Signaling
Ionized calcium (Ca 2+) is the most common signal transduction element in
cells. Numerous Ca2+-specific receptors, ion channels, and proteins use Ca2+ to
control a broad range of cellular processes, including cell motility, muscle
contraction, secretion, and neurotransmission [10]. Not surprisingly, Ca2+ is
regulated by a highly evolved system of cellular machinery.
2.1.1 Regulation in Cells
Normal cytosolic free calcium concentration is approximately 100 nM. This is
orders of magnitude lower than the 1 mM ionized Ca2 concentration found
extracellularly, providing an excellent quiescent state for calcium signal
transduction. Moreover, Ca2+ is also an extremely localized second messenger; it
is estimated that a calcium ion travels approximately 0.1-0.5 ýpm and survives for
merely 50 microseconds before being incorporated by a binding protein [1]. As a
reference, typical cell diameter is approximately 10 gpm.
Local, intracellular free [Ca 2+] can increase from 100 nM to greater than
1 pM. In non-excitable cells, such as blood cells, an inositol (1,4,5)-trisphosphate
(InsP 3)-mediated pathway is primarily responsible for calcium release from
intracellular storage sites [6,37]. Two receptor types are known to discharge InsP 3:
the G protein-coupled receptor class of seven transmembrane-spanning receptors
and the receptor tyrosine kinase [6]. As illustrated in Figure 2-1, InsP 3 acts as an
intracellular second messenger by binding to the specialized InsP 3 receptors that
traverse the endoplasmic reticulum (ER) membrane, triggering release of Ca 2+
from the ER's internal store.
In non-excitable cells, potassium ions (K') leave the cell through open
K+-selective channels, making the inside membrane electric potential more
negative. Ca2+ cations are then drawn more passively down their electrochemical
potential across the plasma membrane through voltage-independent, Ca2+-selective
channels.
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Figure 2-1: Calcium regulation in non-excitable cells
Figure 2-1: Calcium regulation in non-excitable cells
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Excitable cells, such as neurons, possess voltage-dependent Ca2+ channels
in addition to the calcium-homeostatic mechanisms available to non-excitable
cells [37]. Depolarization from the resting membrane potential initiates
conformational changes in the voltage-dependent, Ca 2+-selective ion channels.
This feature enables excitable cells to increase cytosolic free [Ca 2+] relatively
quickly.
In both non-excitable and excitable cells, free intracellular Ca2+ is
sequestered chiefly by the ER. The ER acts as a cellular infrastructure of Ca2+-
binding proteins. Sacro/endoplasmic reticulum Ca2+-ATPase (SERCA) pumps
located in the ER membrane use ATP to move Ca2+ ions into the ER, where they
are trapped by high concentrations of buffer molecules, such as calsequestrin [49].
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Figure 2-2: Calcium regulation in excitable cells
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2.1.2 Documented Calcium Oscillations
Calcium oscillations have been observed in a variety of cells [5,10,22]. The
characteristic of oscillations appears to be unique to each tissue type.
As an example, in non-excitable Xenopus oocytes, InsP 3 is generated by G
protein-linked receptor simulation [5]. InsP3 diffuses rapidly throughout the cell
and occupies receptors for minutes before being degraded. The InsP 3 receptors
release Ca 2+. Calcium release generates high, local calcium concentrations at the
mouth of the InsP 3 receptor channel and inhibits the channel. Ca2+-ATPase pumps
in the ER remove Ca2+ from the cytoplasm, replenishing ER stores of calcium.
Then, the cycle begins again. In the case of Xenopus oocytes, the nominal
frequency of peaks average roughly one every 15 seconds
(or 4 min-') [5].
Furthermore, some authors have shown that the characteristic of calcium
oscillations can be influenced by hormone stimulation. These observations
demonstrate that pathways which control calcium oscillations must exist and
strengthen the hypothesis that calcium oscillations embody frequency-encoded
information. Investigation of rat mesangial cells have shown that the frequency of
oscillations can be controlled with arginine vasopressin (AVP) [22]. As illustrated
in Figure 2-3, raising AVP concentrations from 0.1 nM to 10.0 nM increased
oscillation frequency from 0.17 min-' to 0.49 min-'. AVP caused a sharp rise of
intracellular calcium levels immediately followed by repetitive spikes. In this
study, oscillations were shown to be temperature dependent, which is typical of
biochemical processes.
A [AVP] = 0.1 nM
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Figure 2-3: Calcium oscillations in rat mesangial cells stimulated with varying
concentrations of arginine vasopressin [22].
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2.2 Fluorescence Techniques
Fluorescent probes allow selective, minimally-invasive examination of a particular
component of a complex biomolecular assembly. As illustrated in Figure 2-4, a
narrow optical bandwidth is used for excitation, producing a radially-directed,
fluorescence emission. A detector, orthogonally oriented to the excitation path, is
generally capable of scanning a wide-range of wavelengths.
Shown in Figure 2-5, the emission spectra typically consists of Rayleigh-
scattered excitation light and the fluorescence signal. Quantification is possible if
detection sensitivity is not severely compromised by endogenous background
fluorescence, autofluorescence of cells, or dark current (baseline electrical noise).
sample with fluorescent probe
narrow, bcitation
narrow, bandpass filter
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Figure 2-4: Excitation and emission in a fluorescence experiment.
Monochromatic, excitation light (a) is pasted through an aqueous sample with
fluorescent probe, producing a radially-directed, fluorescence emission (b).
Numerous, fluorescent calcium indicators, such as stil, indo, fura, calcium
green, calcium crimson, are commercially available. This group of dyes offer
relatively bright fluorescence, major shifts in wavelength upon Ca2+ binding, and
high selectivity for Ca2+ over other divalent cations such as Mg2+. These probes
are obtainable in membrane-permeant ester derivatives. Cytosolic esterases split
off the ester groups and leave the membrane-impermeant product trapped in the
cytosol, making these probes suitable for intracellular calcium studies. Cell-
impermeant probes are used for in vitro study.
This thesis utilized calcium green-5n and fura-2 (Molecular Probes,
Eugene, OR) in the free acid (cell-impermeant) form.
2.2.1 Calcium Green-5n Indicator (Single Excitation)
Calcium Green-5n has an effective Kd of 12 jLM for Ca2+, an excitation wavelength
of 506 nm, and an emission wavelength of 531 nm. A concentration of 500 nM of
the probe was used. [Ca 2+] can be determine from calcium green-5n fluorescence
(or from any other single-wavelength calcium indicator) with Equation 2.1.
[Ca2 ]free = Kd - Fmin] (2.1)[F max- F]
where F is the fluorescence of the indicator at experimental calcium levels, Fmin is
the fluorescence in the absence of calcium, Fma, is the fluorescence of the calcium-
saturated probe, and Kd (the dissociation constant) is a measure of the affinity of
the probe for calcium.
absorption
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Figure 2-5: Typical emission spectra. Excitation in the absorption band produces
multiple, longer-wavelength fluorescent species.
intensity
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It should be noted that calculations of free calcium levels using
single-wavelength dyes are inherently less accurate than those measured using
dual-wavelength ratio indicators. Potentially, dual-emission measurements of
calcium should be possible by simultaneous excitation of calcium green-5n and the
calcium- and pH-independent emission isosbestic point of carboxy SNARF-1
(Molecular Probes, Eugene, OR) at 610 nm.
2.2.2 Fura-2 Calcium Indicator (Dual Excitation)
Fura-2 has an effective Kd of 224 nM for Ca2+, dual-excitation wavelength of
340 nm and 370 nm, and an emission wavelength of 505 nm. Spectral shifts that
result from calcium binding allow fura-2 to be used ratiometrically, making the
measurement of calcium concentration essentially independent of the extent of dye
concentration and photobleaching. Quartz glassware is required to sufficiently
transmit the shorter (ultra-violet) excitation wavelengths.
In general, a concentration of 2 ýpM of the probe was used. [Ca2+] can be
determined from fura-2 fluorescence (or from any other dual-wavelength calcium
indicator) using Equation 2.2.
[Ca2+ ]free = Kd [RS (2.2)[R max- R]
where R is the fluorescence X340/X380 excitation ratio of the indicator at
experimental calcium levels, R,,n is the fluorescence ratio in the absence of
calcium, Rm. is the fluorescence ratio of the calcium-saturated probe, Kd is the
dissociation constant, and S is the 380 nm fluorescence ratio in zero calcium to
calcium saturated.

Chapter 3
Theoretical Models
3.1 Relevant Models
While frequency modulation is a familiar topic of the engineering and
mathematical disciplines, frequency-domain analysis is a new technique in the
biomolecular fields. Some recent work has helped provide insight in interpreting
calcium oscillations.
3.1.1 Neural Integration Model
A frequency-domain, neural model achieves temporal integration by exploiting
synaptic efficacy [43]. Neurophysiological studies in the oculo-motor system have
suggested that an integrative operation in the time-domain is required in order to
derive eye position from eye velocity. Early neural models incorporated positive
feedback to achieve an integrative operation; however, they require tight
parameters that are not physiologically plausible.
Because of potentiation, the efficacy of a presynaptic terminal after
stimulation at time zero (t = 0) increases by factor p(t). As depicted in Figure 3-1,
if the presynaptic terminal is then subjected to a second stimulus at some time t,
the postsynaptic signal will be proportional to I + p(t).
Presynapti
naptic potential
a
Synaptic efficacy
0 p(-( t-t.)/ p)
b *I I
-I
• nexp(-(t-tg)Iyp)]p
I I
to t1mb~ time
Figure 3-1: The short term potentiation phenomena in neurons. All traces line up
with the time axis on the bottom of the figure. The top two traces (a) show a
presynaptic firing and the corresponding postsynaptic intracellular potential
change. The bottom two traces (b) show the effect of two successive inputs. The
postsynaptic potential change evoked by the second input is larger due to synaptic
potentiation [43].
I
Experimental observations suggest that p(t) takes the form of a decaying
exponential:
p(t) = ue 'P (3.1)
where u is a constant between 0 and 1 and "p is the potentiation time constant.
A transfer function has been developed for this model [43]. The amplitude
of the excitatory postsynaptic potential (EPSP) is proportional to the amount of
transmitter released presynaptically.
t
EPSP oc (1+ p(t - r)x(r)dr)x(t) (3.2)
where x(t) represents the input firing rate.
Many neurons have a resting firing rate; therefore, x(t)=xo+x'(t), x'(t)<<xo.
Then, x(t) is substituted in its explicit form, and equation 3.2 is expanded:
t
EPSP oc (1 + Jp(t - r)(xo + x' (r)dr)(xo + x' (t)) (3.3)
= (1 + xo p(r)dr)xo + (1 + xo fp(r)dr)x' (t)
0 t (3.4)
+xo f p(t - r)x' (t)dv + x' (t) Jp(t - r)x' (t)dT
--o -. 00
The high-order term is ignored. The first term on the right is moved to the
left, p(t) is substituted in its explicit form (equation 3.1), and the Laplace transform
is expressed in the form of AEPSP.
XoUX'(S)AEPSP oc (1 +x o pu)x' (s) + r p (3.5)
s+1
Assuming a linear proportional relation between the EPSP and the firing
rate of the neuron, the amplitude of the postsynaptic signal can be expressed:
xou X(s)Y(s) = a{(1 + xo p u) X (s ) + ,p /2X(s)} (3.6)
s+l
which gains ca and P3, two proportional constants.
The transfer function is given in equation 3.7. The single pole function
suggests that high frequency presynaptic inputs are passed through and that
sub-threshold frequencies are attenuated. This response has been experimentally
observed.
? (s) ax ounpH(s)- ) = u(1 +xoUpr- fl)+ U (3.7)
X(s) s + l
The neural integration model is relevant to this thesis since repetitive
presynaptic inputs share similarities with calcium oscillations and synaptic efficacy
is analogous to the rate of protein deactivation. Applying the model's high-pass
response in the context of calcium oscillations supports the notion that calcium-
activated enzyme systems act as biomolecular integrators or "spike counters".
Maximal enzymatic activity is therefore achieved once the frequency of calcium
oscillations surpasses an intrinsic threshold frequency. The neuron's synaptic
efficacy defines the rate of presynaptic input necessary for the entire system's
integrative response. As described in below, the deactivation time constant of each
calcium-activated protein (presumably in an assembly of proteins) is governed by
its own unique rate of deactivation.
3.1.2 Cooperative, Autophosphorylation Model
Ca2+/calmodulin-dependent protein kinase (CaM kinase) has been proposed as a
decoder of calcium signals [19,35]. CaM kinase, involved in neurotransmission,
gene expression, ion channels, and cell cycle, possesses unique properties that
facilitate calcium oscillation frequency detection:
* multiple activity states: 8-10 subunits are individually regulated by
Ca2+/calmodulin providing a relatively wide range of total enzymatic activity.
* slow protein deactivation: As illustrated in Figure 3-2, Ca2+/calmodulin-
dependent autophosphorylation of Thr 286 (instead of the autoinhibitory segment
of the regulatory domain) yields an interesting CaMK P (autonomous) state [35].
The protein "traps" calmodulin even at sub-threshold Ca2+ concentrations.
Even after the calmodulin molecule unbinds, the protein remains partially
active (20%-80%).
* protein memory: CaMK P subunits not only continue to phosphorylate
substrates, but also autophosphorylate CaMKo (inactive) subunits. This ability
to propagate the autonomous state through CaMKO autophosphorylation in the
absence of Ca2+/calmodulin is an important "memory" feature of CaM
kinase.
Computer simulations support the model that CaM kinase enzyme system
may act as a decoder of calcium signals [35]. The repetitive calcium pulses may
yield a cooperative, positive feedback loop that will potentiate the response of the
kinase to sequential Ca2+ transients.
inactive kinase subunit
(0% activity) CaMKo
bine
a
4 to Thr286
nit
Si uuv/o activuty)
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slow unbinding
of CaM from Thr286
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Figure 3-2: State diagram of CaM kinase subunit
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3.2 Proposed Enzyme Activation/Deactivation Model
Calcium-activated enzymes, once bonded to calcium, can transform substrate
molecules into altered products. As shown in equation 3.8, enzyme, substrate, and
calcium cofactor combine to form an enzyme-substrate-calcium complex. This
complex can then degrade into its starting components unchanged or give rise to a
new product along with original enzyme and cofactor.
enzyme + Ca2+ + substrate -- complex +• enzyme + Ca2+ + product (3.8)
Enzymatic activity-the amount of product yielded over a given period of
time-is tightly influenced by calcium concentration. With calcium-activated
enzyme systems, a change of 10 nM - 1IM of free calcium concentration can
result in as much as a 100-fold change in activity [19].
3.2.1 Frequency-domain Enzyme Kinetics
In the static case (when calcium concentration does not change), the simple model
presented in equation 3.8 holds. However, in the context of calcium oscillations,
considering the enzyme to exist in either an active or an inactive state is
conceptually useful. The proposed model makes this assumption.
inactive enzyme + Ca2+ - active enzyme (3.9)
active enzyme -- inactive enzyme + Ca2+  (3.10)
active enzyme + substrate f active enzyme + product (3.11)
As shown in equation 3.9-3.11, the enzyme serves as a switch with calcium
as the input signal. When the calcium signal goes "high", inactive enzyme
combines with calcium cofactor, resulting in a conformational change that
activates the enzyme. Only the enzyme in its active form can process substrate.
When the calcium signal goes "low", calcium unbinds and the enzyme becomes
inert, returning to its inactive state.
The proposed model considers the activation and deactivation delays
associated with these reactions, as shown in equations 3.12 and 3.13 and
Figure 3-3. When the cofactory species is rapidly introduced to a system (i.e. in
the form of a step function), the population of activated enzyme (AE) molecules
increases exponentially [14,19]. The rate of activation can vary between different
enzyme systems.
[activatec
time
Figure 3-3: Activation delay. This sketch illustrates the delay in activated enzyme
concentration associated with following a calcium step. Both plots line up with a
common time axis and are not drawn to scale. [Ca2+ ]bound = [activated enzyme].
[Ca 2+]free = [Ca 2 +]total - [Ca 2 +]bound.
During the calcium high to calcium low transition state, the concentration of
activated enzyme takes the form of a decaying exponential. This is analogous to a
discharging capacitor.
[active enzyme](t) oc ([Ca2 +]high-[Ca2 + ]ow) e 2'+[Cao, w (3.12)
where rd is the deactivation time constant. zd has been observed to range from
microseconds (ps) to 20 seconds across enzymes [43].
Conversely, during the calcium low to calcium high transition state, the
concentration of activated enzyme takes the form of a rising exponential [14,19].
Again, this is similar to a charging capacitor; however, the activation and
deactivation time constants do not have to be identical.
[active enzyme](t) oc [Ca2+]high(l-et") +[Ca2+],ow e-t"r (3.13)
where z, is the activation time constant. Since empirical values of r, could not be
found, the assumption that za exists in the same range as rd is made.
In the context of calcium oscillations, activation and deactivation times may
potentially play a large role in frequency-domain kinetics. Consider the case
where the rate of activation is fast and the rate of deactivation is slow relative to
the frequency of oscillations. During the [Ca2+ ]ow phase, the fraction of enzyme
molecules that still have bounded calcium (due of slow deactivation) remains
active. At the next calcium spike, both these molecules and the newly activated
enzyme are in the active form. This additive effect continues with each calcium
peak until a steady state wherein the number of newly activated enzyme molecules
in the [Ca2+]high pulse equals the number of inactivated enzyme molecules during
the [Ca2+]low pulse.
Computationally, the slow to deactivate enzyme acts as a "calcium peak
counter". This provides an attractive explanation to why in vitro assays of some
enzymes, such as calpain type I, curiously require millimolar calcium
concentrations to obtain the same activity achievable with micromolar calcium
concentrations in vivo [45].
Furthermore, different enzyme systems have widely varying calcium
requirements and activation/deactivation characteristics. This suggests that each
protein is likely to have an unique, response to the frequency of calcium
oscillations. In this context, calcium oscillations could represent a versatile,
intracellular signal with the ability to "turn on" a particular enzyme system without
disturbing others.
Though similar selective control is also conceptually possible with the
traditional, static model, many additional cofactory and inhibitory "signals" would
be required. From an engineering perspective, this encoding paradigm would
minimally grow on the order of log2(n) for a system with n calcium-activated
proteins and would require fast transitions for all signals. Clearly, such inefficient
use of bandwidth and tight constraints must also be unattractive from a
biological/evolutionary standpoint.
3.2.2 Computer Simulations
A gee (GNU C compiler) simulation was developed to demonstrate that the
activation/deactivation, frequency-encoding model is feasible at physiologically-
relevant conditions. A square-wave calcium drive is generated from the user's
selection of frequency of oscillation, [Ca2 ]high, and [Ca2+]low parameters.
The concentration of activated enzyme as a function of time is influenced
by the protein's activation and deactivation delays (in response to the oscillating
calcium drive) and are calculated as previously described (equations 3.12 and
3.13). The za and Td time constants are provided by the user. The enzyme's
affinity for calcium is assumed to be sufficiently high and the concentration of
substrate is assumed to be much greater than the concentration of enzyme.
Moreover, all enzyme molecules may become active if the [Ca 2+] remains "high"
for enough za time constants.
Only activated enzyme can yield product from substrate. Shown in
Equation 3.14, the Michaelis-Menten model describes the conversion of substrate
to product. The inactivated enzyme is not considered, since the simulator assumes
that it does not compete for substrate. The concentration of activated enzyme
changes due to the availability of calcium. Therefore, the total amount of activated
enzyme ([AE]tota), is re-computed with each iteration of the simulator. [AE]to,,,,
includes free activated enzyme and activated enzyme bound to substrate.
ki
AE+ S AES-- )AE+P (3.14)
k2
where AE is activated enzyme, S is substrate, AE*S is activated enzyme-substrate
complex, and P is product.
Equation 3.14 may be modeled as a linear time-invariant compartmental
system, permitting a lumped-parameter representation of each compartment. As
such, mass action law and Conservation of Mass yield a family of differential
equations that describes each constituent in the time-domain.
d[AE]
= -k,[ AE][S][Ca2+ + (k 2 + k3)[AE * S] (3.15)
dt
d[S] d[S= -k, [AE][S][Ca2 ] + (k2)[ AE * S]
dt
d[P]
dt
d[AE]
dt
= k2[ AE e S]
-d[AE e S]
(3.16)
(3.17)
(3.18)
(3.19)
To determine the amount of product yielded over time, Vma(t) (the maximal
velocity or rate of the reaction with units of mol/second) is determined from
equation 3.15, assuming [AE * S] = [AE] (i.e. all of the activated enzyme is
bound to substrate).
V, (t) = k,[ AE](t)
V(t) = Vý (t) [S]+ Km-substrate
(3.20)
(3.21)
where V is the velocity of the reaction, Vm,, is the maximal velocity of the reaction,
k3 is the forward rate constant, and Km-substrate is the Michaelis constant.
Since [S] is assumed to be relatively large compared to the Michaelis
constant, equation 3.21 can be reduced. Finally, product calculated by integrating
the reaction velocity over time.
V(t) = Vmý(t)
product(t) = i V(t)dt
(3.22)
(3.23)
d[AE . S]
dt
k, f AE][S]f[Ca2 ]-(k 2 + k3)[AE *S]i
Four hypothetical enzymes were explored: protein FF (fast activation, fast
deactivation), protein FS (fast activation, slow deactivation), protein SF (slow
activation, fast deactivation), and protein SS (slow activation, slow deactivation).
Each protein had a unique Ca and 'd combination, while identical k3 and all other
values were used. These parameters were chosen from a physiologically observed
range [10,14], but do not necessarily represent a known enzyme. Values are
provided in Table 3-1. [E]totat = 200 nM. [S]initiai = 5 gM.
Table 3.1: Simulation parameters (protein FF, FS, SF, SS)
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Protein Ta Td k3
(second) (second) (nM/second)
FF 1 x 10 3  1 x 10"3  10
FS 1 x 10-3  2 10
SF 2 1 x 10-3  10
SS 2 2 10
For each protein, three simulations were conducted. The first simulation
generated a time course of product yielded over 5 minutes with calcium
oscillations at a frequency of 0.5 min' (physiologically observed). Simultaneous
time courses of the total intracellular calcium concentration and active enzyme
concentration were also provided.
The second simulation repeated the first with calcium oscillations at a
higher frequency of 4 min' (also physiologically observed).
The third simulation provided the normalized total product yielded in
5 minutes over a wide range of frequencies from near static calcium levels to a
frequency of approximately 12 min' (not physiologically observed). As described
in equation 3.24, total product was averaged to time-averaged calcium
concentration (avg[Ca2+]).
normalized total product = total product /avg[Ca2+] (3.24)
The computer simulation makes several assumptions:
* an enzyme molecule is either completely active or completely inactive
* exactly one calcium ion is required for enzyme activation
* inactive enzyme molecules do not compete for substrate
* substrate is not transformed to product without active enzyme
The simulator's tab-delimited output file was imported by Matlab
(The MathWorks, Boston, MA). The results, reported graphically, are provided in
Figure 3-4 through Figure 3-15. For accurate comparison, all plots use consistent
scaling with the exception of the product time course (not normalized).
protein FF (freq=0.5 min^-l)
0 100 200 300 400 500 600
0 100 200 300 400 500 600
u uU 200 300 400 500 600x 10
21 ......... ....... · ...... ... . ... ....... ....... . .. ..... ..... .:..........
0
0I
0 100 200 300 400 500 600
time (seconds)
Figure 3-4: Computer simulation of fast activation, fast deactivation protein,
oscillations at 0.5 minm1. All time courses share a common time axis. The top plot
(a) shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-5: Computer simulation of fast activation, fast deactivation protein,
oscillations at 4 min'1. All time courses share a common time axis. The top plot (a)
shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-6: Computer simulation of fast activation, fast deactivation protein over a
range of frequencies. It should be noted that increased normalized product is
observed at higher frequencies not included in this plot.
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protein FS (freq=0.5 min^-l)
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Figure 3-7: Computer simulation of fast activation, slow deactivation protein,
oscillations at 0.5 min-l . All time courses share a common time axis. The top plot
(a) shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-8: Computer simulation of fast activation, slow deactivation protein,
oscillations at 4 min-'. All time courses share a common time axis. The top plot (a)
shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-9: Computer simulation of fast activation, slow deactivation protein over
a range of frequencies. The apparent "noisiness" at lower frequencies is the result
of the small number of calcium spikes included in the very low frequency
calculations.
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protein SF (freq=0.5 min^-1)
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Figure 3-10: Computer simulation of slow activation, fast deactivation protein,
oscillations at 0.5 min-'. All time courses share a common time axis. The top plot
(a) shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
protein SF (freq=4 min^-1)
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Figure 3-11: Computer simulation of slow activation, fast deactivation protein,
oscillations at 4 min"'. All time courses share a common time axis. The top plot (a)
shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-12: Computer simulation of slow activation, fast deactivation protein over
a range of frequencies. It should be noted that increased normalized product is
observed at higher frequencies not included in this plot.
I & i I I -I i
o
01.5
0
CL
S1
0.5
0
(
I .
k
protein SS (freq=0.5 min^-1)
.. ...........
100
0
x 10
100
200
200
300
300
400
400
20
II I I
I I I I
100 200 300
time (seconds)
400
Figure 3-13: Computer simulation of slow activation, slow deactivation protein,
oscillations at 0.5 minm 1. All time courses share a common time axis. The top plot
(a) shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-14: Computer simulation of slow activation, slow deactivation protein,
oscillations at 4 min'. All time courses share a common time axis. The top plot (a)
shows total intracellular calcium concentration, the middle plot (b) provides
activated enzyme concentration, and the bottom plot (c) presents a time course of
product generated.
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Figure 3-15: Computer simulation of slow activation, slow deactivation protein
over a range of frequencies. The apparent "noisiness" at lower frequencies is the
result of the small number of calcium spikes included in the very low frequency
calculations.
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Figure 3-16: Composite of FF, FS, SF, SS simulation results.
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The results from the four simulations demonstrate the roles of activation
and deactivation rates in the proposed encoding model. As predicted, when
deactivation is slow relative to the frequency of calcium oscillations, the
concentration of bonded calcium is influenced by the frequency of calcium
oscillations. As illustrated by Figure 3-17, the enzyme's frequency response is
determined by the rate of deactivation. Slower deactivation leads to a greater
sensitivity to frequency. Meanwhile, activation rate appears to have a
multiplicative, scaling effect.
varying deactivation rates (T=5 min)
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Figure 3-17: Computer simulation of multiple, fast activation proteins with varying
deactivation rates over a range of frequencies. From slower deactivation to faster
deactivation, 'd = 1, 0.5, 0.1 second. For all plots, Ta = 0.001 second.
3.2.3 Calcium Oscillations and the Michaelis Constant
In protein biochemistry, common practice is to characterize mutant enzymes by
their Vmax and Km-substrate values relative to the wild-type enzyme. A change in
Km-substrate suggests a modified substrate-binding site, while an alteration in Vm,
suggests altered catalytic ability.
The Lineweaver-Burk plot is derived simply by taking the reciprocal of
both sides of the Michaelis-Menten relationship (equation 3.21):
1 1 km + [S] (3.20)V V [S] V [S]
km + [S]
rearranging:
1 km 1 1
-- = +-- (3.21)
V Vm= [S] VP
where plotting 1/V versus 1/[substrate] yields a straight line with slope K,/Vmax, an
intercept of 1/Vma, on the 1/V axis, and an intercept of -1/Km on the 1/[S] axis.
As illustrated in Figure 3-18, a special Lineweaver-Burk plot was made to
determine Km-caicm using data from protein FS simulations over a range of calcium
oscillation frequencies. For each frequency, 3 data points were obtained from the
run's velocity (V), determined by the product endpoint, and the run's time-
averaged calcium concentrations. To produce a Lineweaver-Burke plot, it was
necessary to vary avg[Ca2+] between simulations. This was accomplished by
altering the amplitude of the simulated intracellular calcium oscillations. Finally,
1/V was compared to 1/(avg[Ca2+]).
As frequency increased, the K.caicum, of protein FS decreases. Clearly, the
enzyme's affinity for calcium does not change with respect to frequency. Rather,
activity/avg[Ca'] increases with the frequency of calcium oscillations. This
interpretation is consistent with the computer simulations.
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Figure 3-18: Lineweaver-Burk of protein FS over a range of frequencies.
Increasing frequencies yields decreasing K.,,caium values. This suggest greater
apparent activity for equal time-averaged calcium concentration at higher
oscillation frequencies. Stars (static calcium concentration), crosses (calcium
oscillation at 0.5 min"1), x-mark (2 min"'), circles (4 min').
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3.2.4 Calcium Oscillations as Control Signal
Different enzyme systems have widely varying calcium requirements and
activation/deactivation characteristics. Therefore, two calcium-activated enzymes
could interpret (or decode) the same calcium oscillation differently. This "filtering
effect" implies a means to selectively activate a particular enzyme system without
affecting others.
An additional series of computer simulations were conducted with two
hypothetical enzymes D and G. Enzyme D has a greater Vma x than enzyme G, and
enzyme G has a slower rate of deactivation than enzyme D. Shown in Table 3.2,
physiologically-relevant simulation parameters were selected [43].
As illustrated in Figure 3-19, the activity (i.e. rate of substrate to product
conversion) of enzyme D is greater than the rate of enzyme G at lower frequencies.
However, at higher frequencies enzyme G's activity overtakes that of enzyme D.
This is biologically meaningful if both enzymes are involved in the same metabolic
Table 3.2: Simulation parameters (protein D, G)
Protein Ta Td k3
(second) (second) (nM/second)
D 1 x 10-3  1 x 103  20
G 1 x 10-3 1 10
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Figure 3-19: Computer simulation of two calcium-activated proteins over a range
of frequencies.
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pathway. For example, enzyme D and enzyme G could serve as a frequency-
dependent switch in the hypothetical pathway shown in Figure 3-19. If both
enzymes compete for the same substrate, an increase in the frequency of calcium
oscillation would make end product H favored over end product F.
3.2.5 Artificial Calcium Oscillations as an Investigative Tool
Precise activation/deactivation measurements are often difficult or impossible to
achieve through traditional means [8]. Artificial calcium oscillations, however,
may serve as a new tool for studying enzyme systems. Computer simulations have
shown that protein activation rate can be determined using calcium drives with
varying "on" times and "off' times that are long enough to neglect the effects of
calcium unbinding. Conversely, the calcium unbinding rate can be determined
using calcium drives with varying "off" times and a sufficiently long "on" time.
protein D
A --- B - C
protein G
D - E F (low frequency
end product)
G H (high frequency
end product)
Figure 3-20: Frequency-dependent metabolic pathway.

Chapter 4
Instrument Design
4.1 Prototype Design
Artificial calcium oscillations are generated by the precise addition of small
volumes of calcium and EGTA (a calcium chelator) solutions. The EGTA
molecule, through its high local concentration of combining groups, form an
octahedral arrangement around a calcium ion and is effective in removing free
calcium from buffer [21]. As will be described, an instrument was built to
precisely control sequential additions of Ca2+ and EGTA and was able to generate
the user defined calcium signals shown in Figure 4-1.
artificial oscillations
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Figure 4-1: Artificial calcium oscillations
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As illustrated in Figure 4-2, the prototype comprised of two independent
systems: one that continuously monitored calcium concentration and another that
generated calcium oscillations.
calcium monitoring equipment
calcium oscillation
generating equipment
Figure 4-2: Block Diagram of experimental setup
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4.1.1 Control Circuit
Calcium and EGTA release are driven by a control circuit. As shown in
Figure 4-3, the first implemented was an analog system based on a cascade of 555
timer circuits. Changing the resistive value of potentiometers allowed the user to
control the timing characteristics of the astablely-driven circuit. Unfortunately,
this design proved to be unreliable and difficult to modify.
Vcc
gnd
Figure 4-3: Control circuit, analog implementation.
pum;
pump B
The second implementation, illustrated in Figure 4-4, employed a digital
system that utilizes a PIC16C56, BASIC interpreter (Parallax, Inc., Rocklin, CA)
clocked at 4-MHz, a 256-byte EEPROM (electronically erasable programmable
read-only memory), and a parallel communication port.
2400 baud connection to
computer (via parallel port)
1-50 kOhm potentiometer
1-50 kOhm potentiometer
Figure 4-4: Control circuit, digital implementation.
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BASIC source code is developed on an Intel-based PC and downloaded to the
control circuit via a parallel connection. The source code is then transferred and
stored in the non-volatile EEPROM. The BASIC interpreter executes the
instructions which can include (but are not limited to) mathematical computations,
Boolean operations, and evaluative branching.
Two dedicated lines allow the control circuit to activate and deactivate calcium
and EGTA release. Another two dedicated lines allow the interpreter to
independently read two 1-50 kM potentiometers which serve as user input. ASCII
text can be transmitted to the PC's display via the parallel connection. Components
of the control circuit are synchronized to the rising edge of a 4 MHz square wave
generated by an onboard resonator.
The digital implementation provides the following advantages:
* timing is accurate to within 1 ms
* calcium signals can be changed through source code
* modifications rather than through time-consuming hardware redesign
* complex signals that require mathematical computation or
* irregular iteration can be accommodated
* status reports can be sent to the computer screen
* user input can be evaluated in real time
4.1.2 Source Code
In the attempt to improve calcium signals, 4 major source code revisions were
made. Hardware modifications were not required.
* revision 1: scripted calcium and EGTA release. The amount of solution
released is hard-wired by a pre-written script.
* revision 2: computed calcium and EGTA release. The amount of solution
release is computed by the starting volume of the solution, the of EGTA, and
the amount of calcium and EGTA already released.
* revision 3: user-biased calcium and EGTA release. The amount of solution
released is still computed by the control circuit, but now biased by the user's
potentiometer input.
* revision 4: status report feedback. The current status of the control circuit is
displayed on the computer screen, allowing the user to make informed
adjustments. Sample feedback is shown in Figure 4-4.
EDTA 4 10 + 2
EDTA 2 10 + 2
EDTA 0 10 + 2
ca2+ 8 8 + 4
Figure 4-5: Revision 4 status report. The first line translates to "EGTA will be
released in 4 seconds. The control circuit has computed that 10 ýtL of solution
should be released. The user has added an offset of 2 [pL. If the potentiometer is
not adjusted within 4 seconds, then 12 [tL of EGTA will be released."
4.1.3 Delivery Systems
The control circuit is compatible with two delivery systems:
* Low-flow MasterFlex L/S high-accuracy pumps (Cole-Parmer Instrument
Company, Niles, Illinois). The 0.5 RPM synchronous motor delivers
30 mL/min of fluid at 0.1 accuracy when used with size 13 tubing.
Modifications were made to interface the drive units with the control circuit.
Unfortunately, the pumps proved to be inconsistent at short duty cycles.
* Sub-miniature series 3 solenoid values (General Valve Corporation, Fairfield,
NJ). When the electronically-controlled 6 volt valves are over-driven at 9 volts,
the total response time (the sum of the open-close and close-open transition
delays) is less than 8 ms with 1% variance. At pressures between 5-15 psi, the
valves proved to be reliable in releasing volumes ranging from 12-120 pL.
4.1.4 Known Limitations
There are two known limitations:
* Calcium buffering. Though the concentration of free calcium oscillates, the
total calcium of the system continues to increase with each calcium release.
Once total calcium reaches high enough levels, the system becomes calcium
buffered: the amount of calcium that dynamically disassociates with EGTA
becomes non-negligible. Calcium buffering limits the number of good
oscillations that can be generated. Clearly, this problem prevents high
frequency oscillations to be sustained for a long duration.
* Calcium green-5n dilution. The emission intensity of calcium green is affected
by dilution. Since the reduction of intensity is linearly proportional to dye
concentration, a corrected calcium concentration can be easily determined for
small dilutions. Larger dilutions, however, may result in inaccurate readings.
This limitation prevents the amount of solution that can be introduced.
4.2 Benchtop Design
A sturdy, benchtop calcium oscillator is currently under construction. Like the
prototype, the calcium oscillator is a microprocessor controlled general purpose
in vitro calcium cycler. The following features are unique to the benchtop unit:
* The entire system (electronics, fluorescent optics, valves and tubing,
temperature control, magnetic mixing mechanism) exists as a single
self-contained unit.
* The menu driven interface is logically arranged and similar to that of the
Ericomp TwinBlock System (PCR temperature cycler) which is currently
widely used.
* Feedback optics may yield better control of artificial oscillations.
* Two photo-detectors permit the use of dual emission fluorescent probes.
Schematic diagram and operating instructions are provided in Figure 4-6
and Figure 4-7, respectively.
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Figure 4-7: Operating instructions for benchtop calcium oscillator
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Figure 4-6: Schematic diagram of benchtop calcium oscillator
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Chapter 5
Results and Analysis
5.1 Experimental Technique
Three calcium-activated enzymes were studied: the 14 kDa
phospholipase A2 (PLA2), calpain type I, and calcineurin. Similar experimental
procedures were exercised for each enzyme system.
* First, a reliable assay was established to quantify enzymatic activity. In all
experiments, activity was defined as the amount of product yielded per time
unit. Unlike the computer simulations provided in subsection 3.2.2, continuous
time measurements were not employed. Therefore, between-experiment
activities were compared by evaluating measurable product available at a
predetermined time interval.
* Then, the activity of the enzyme was determined at different static
concentrations of calcium. These results were compared to published
observations to verify the soundness of the assay method.
* Next, assays were then conducted in the context of artificial calcium
oscillations at frequencies ranging from 0.5 min-' to 4 min-'. In these
experimental runs, the time-averaged calcium concentrations of the artificial
oscillations was set to approximately that of the enzyme's calcium requirement
for half-maximal activity. Since the time-averaged calcium concentrations of
the experimental runs were the same, the effect of frequency could be easily
evaluated. Fluorescent calcium indicators allowed continuous-time
measurements of free calcium concentration to be recorded for each assay.
Finally, an attempt was made to create custom analytical software to
scrutinized empirical results for frequency-dependency (method described in
appendix). Additional assays were included in the aggregate data set by
attempting to compared runs with different time-averaged calcium
concentrations with the Lineweaver-Burk relationship. The supplementary
data primarily comprised of runs previously discarded because the generated
artificial calcium oscillations deviated from what was desired. Moreover, the
software offered a potential means to account for variability in the artificially-
generated, calcium oscillations and to estimate activation and deactivation time
constants. In retrospect, however, the utility of the analytical software was
questionable especially since calcium was incorrectly assumed to be the
limiting factor of the enzymatic reaction.
5.2 Phospholipase A2
5.2.1 Model
Phospholipases comprise of a family of enzymes that catalyze the hydrolysis of
phospholipids. Phospholipase A2 (PLA2) cleaves the acyl bond at the sn-2
position, releasing free fatty acids and lysophospholipids [12]. These products
may serve as intracellular second messengers. PLA2's involvement in signal
transduction and its own regulation by calcium warrant investigating the role of
PLA 2 in the setting of calcium oscillations.
Proven techniques have been established for studying most enzymes that act
on water-soluble substrates. However, PLA2, a membrane enzyme, follows a more
complicated model where an enzyme surface interacts with a lipid surface.
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Additional issues are considered:
* Phospholipid substrates. With water-soluble substrates, it is often sufficient to
know the chemical structure and concentration of the substrate. With
phospholipid substrates, one must also know the physical structure of the
phospholipid since small changes in molecular structure can greatly effect the
activities of enzymes [34]. This clearly complicates kinetics analysis.
Detergents are often added to minimize differences in the surface structure of
the substrates [16].
* Interfacial catalysis. The current kinetics model involves two steps [27]. The
first step involves the bulk action of binding to the phospholipid aggregate. In
the second step, a topologically distinct catalytic site binds to a phospholipid
molecule. This is similar to the formation of a classical Michelis-Menten
complex. However, the enzyme-now anchored to the interface-can only
move in two dimensions (or scoot) [11]. In theory, a single molecule could
processively hydrolyze all exposed substrate of a single phospholipid vesicle
without leaving the interface. Scooting mode catalysis has been observed for
PLA 2.
5.2.2 Assay
PLA 2 activity was assayed by using radioactively-labeled liposomes prepared by
votexing phophatidylethanolamine (1-acyl-2-(1-C 14)PE, 55 mCi/mmol, from
Amersham), ddH20, and the non-ionic detergent 1 Triton-X 100 (1:10:0.1, by
volume) for 30 seconds immediately before the reaction. The reaction buffer (1.5
mL) contained 100-200 ýig (290 nM) bovine pancreatic, type II sPLA2 (obtained
from Sigma Chemical Company, St. Louis, MO) 20 mM NaCi, 115 mM KC1, 1
mM MgCl 2, and 10 mM MOPS at pH 7.3. Assay buffer and substrate were
to 37 'C. Then, the solutions were combined and pre-incubated for 5 minutes in a
low calcium environment. Next, the reaction proceeded with artificial calcium
oscillations for 7.5 minutes. Calcium oscillations were generated as discussed in
chapter 4. Finally, the reaction was stopped with Dole's reagent in water, and the
fatty acids released were extracted as previously described [29]. Radioactivity
(weak alpha) was measured with a Packard Tri-Carb liquid-scintillation
spetrophotometer.
5.2.3 Results
Over 100 individual PLA2 assays were conducted. Techniques were refined in the
attempt to achieve more consistent results. Preparing liposomes with detergent,
preheating reagents, and pre-incubating reduce some between-experiment
variability; however, noisy results persisted. Figure 5-1 shows the result of 16
assays. The target time-averaged calcium concentration was 2.5 gtM for all assays.
Numerical results are given in Table 5.1.
Table 5.1: PLA2 assay results.
frequency product standard error n
(min-) (counts/min) (counts/min)
static 1576 39.36 6
0.3 1567 193.94 4
4 1699 204.0 6
PLA_2 Assays (n = 6,4,6)
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
frequency (oscillations/minute)
Figure 5-1: PLA2 assays results. Time-averaged [Ca2+] was 2.5 ýpM for these runs.
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5.2.4 Analysis
The results do not show a statistically significant frequency-dependent trend
(Figure 5-1) A possible factor contributing to measurement noise is PLA2's
millimolar calcium requirement for half-maximal activity (orders of magnitude
greater than what the artificial calcium generating system can accommodate).
Experimental noise was augmented by short assay times (again, required by
experimental setup). Several interpretations, however, can be drawn from the data:
* The artificial calcium oscillation amplifies noisiness in the assay of PLA2
activity. Table 5.1 and Figure 5-1 how a 5-fold increase in standard error
between static concentrations of calcium and calcium oscillations.
* The best fit activation and deactivation time constants (as determined by the
analytical software) for the three dynamic cases were comparable. This
partially helps validate the earlier claim that the characteristics of the bonded
calcium transients are frequency-independent.
* The best fit activation and deactivation time constants were short relative to the
time scale of calcium oscillation, suggesting that no frequency dependency
should be observed.
Further study of PLA2 was abandoned in order to investigate more
promising enzyme systems, such as calpain and calcineurin. PLA2's noisy activity
measurements and complicated interactions with the lipid surface of the substrate
compromised the reliability of the assays, ultimately making results difficult to
interpret.
5.3 Calpain
5.3.1 Model
Calpains are calcium-activated proteases. There are two major isoforms:
type 1 (gp-type) that requires micromolar amounts of free calcium and type 2
(m-type) that requires millimolar amounts of free calcium. Both forms are present
in the cytosol of most cells [39]. Enhanced activity of calpain is believed to be
involved in the pathology of cerebral ischemia, cataracts, myocardial ischemia,
muscular dystrophy, and platelet aggregation [39]; therefore, calpain is currently
the center of exhaustive investigation. Better understanding this enzyme may have
significance for pharmacological development.
Calpain may represent a unique decoder of calcium signals. It is known
that in vitro calcium requirements are much greater than physiologically
observed:
One of the long-addressed questions about the in vivo calpain activation
mechanism concerns the discrepancy between the in vitro calcium
requirements of calpain and the physiological intracellular calcium
concentrations; even calpain requires more than 10-6 M calcium in the
test tube for activation whereas the intracellular calcium concentration
usually fluctuates between 10-8 and 10-6 M. In fact, most studies
describing in some detail in vitro substrate proteolysis by calpain have
used near-millimolar levels of calcium to active the protease. This is
more than 103-fold higher than the normal intracellular range, casting
doubts about the physiological relevance of such observations. [45]
This discrepancy in calcium requirement makes calpain an excellent candidate for
study in the frequency domain. As discussed in chapter 3, in the case where the
period of oscillation is short compared to the time scale of protein deactivation, the
repetitive calcium peaks may yield an additive effect, explaining apparent enzyme
activity at low calcium concentrations.
5.3.2 Assay
Two methods were explored to assay calpain's activity:
* Calpain activity can be continuously assayed by observing the change in
spectra of its fluorescent substrate, Suc-Leu-Tyr-MCA [42]. Calpain cleaves
the substrate at the Leu-Tyr bond, causing the emission peak to shift from 340
nm to 370 nm, allowing enzymatic activity to be determined. Calpain is
normally assayed with kexcitation = 370 nm @ 75W, remission = 460 nm, and dye
concentration = 1 mM. Conveniently, its fluorescence emission maximum is
separated from that of calcium green-5n, potentially allowing calpain activity
and calcium concentration to be monitored simultaneously. The assay buffer
(1.5 ýpL) contains 10 [pg of calpain, 5 mM L-cysteine, 2.5 mM
2-mercaptoethanol, 2% Me2SO, 2% methanol, and 110 mM imidazole HCl at
pH 7.3. Calpain and the Suc-Leu-Tyr-MCA substrate, were obtained from
Calbiochem and Novabiochem, respectively.
* A colorimetric test assay was also conducted [39]. A calpain assay buffer,
containing 20 mM imidazole, 1 mM EDTA, ImM EGTA, and
5 mM 2-mercaptoethanol, was prepared. This buffer was combined with
89.1 nM of enzyme, 50 mM cysteine, 4% casein in 0.5 M imidazole HCI buffer
at pH 7.5, and ddH20 (5:1:1:1:2 by volume) and allowed to incubate at 30 oC.
After 15 minutes, the reaction was stopped with an equal volume of
10% trichloroacetic acid (TCA) to alter the pH and precipitate undigested
casein out of solution. The mixture was centrifuged at 12,000 RPM for
10 minutes. 0.4 ml of supernatant was combined with 0.1 ml of 0.7 M sodium
carbonate in 0.1 N NaOH, 0.1 ml of 2 M monoiodacetic acid in 2 N NaOH, and
2 ml of 0.5% copper sulfate, 1% sodium-potassium tartrate, and 1.5% sodium
carbonate in 0.1 N NaOH (1:1:50 by volume). After 10 minutes, 0.2 ml of
1 N Folin Phenol reagent was added and vortexed immediately. After 30
minutes, absorbence, or "optical density" (OD), at 750 nm was read using a
spectrophotometer. With this assay, one unit of calpain activity changes the
OD value by 1.0. Bovine serum albumin (BSA) was used for a "blank"
measurement.
The fluorescent calpain assay is preferred because it allows a continuous-
time measurement of activity. This technique would be especially useful in
determining calpain's response to an artificial calcium spike. The fluorescent
method, however, could not be successfully implemented even after considerable
time investment. Instead, the colorimetric casein assay was used because it
produced consistent and reliable results.
5.3.3 Results
Figure 5-2 shows the result of 8 assays. The target time-averaged calcium
concentration was approximately 5 ýpM for these assays. Numerical results are
given in Table 5.2.
frequency product standard error n
(min-') (OD/min) (OD/min)
static 0.24 0.020 2
0.3 0.29 0.036 2
2 0.21 0.040 2
4 0.22 0.040 2
Table 5.2: Calpain assay results
0.7
0.6
0.5
0.4
0.3
0.2
Calpain Assays (n = 2,2,2,2)
iI I I
freq = 0 is static case
I I
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
frequency (oscillations/minute)
Figure 5-2: Calpain assays. Time-averaged [Ca 2+] was 5 ýIM for these runs.
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5.3.4. Analysis
The assay results reveal no frequency-dependency over the range explored
(Figure 5-2). Additional assays with shorter incubation times were conducted at
high frequencies up to 8 min"', but a frequency response was still not observed.
Several interpretations can be drawn from the data:
* Calpain may be a fast activating, fast deactivating enzyme similar to
protein FF, modeled in section 3.
* The artificial calcium generating system is not measurably disrupting
the in vitro system since frequency and therefore the number of artificial
calcium spikes do not affect the activity of calpain.
* It is possible the EGTA is also reacting with a cofactor whose absence prevents
manifestation of the frequency response.
5.4 Calcineurin
5.4.1 Model
Calcineurin (CN) is a 17 kDa calcium-activated phosphatase involved in T cell
activation. CN is a heterotrimeric complex that consists of three subunits: a
catalytic subunit (CnA) and two regulatory subunits: CnB and calmodulin (CaM)
[35]. The CnB subunit is similar to CaM (previously discussed in chapter 3).
Both proteins have four calcium binding loops; however, CnB has a much higher
affinity for Ca 2+ than CaM.
As shown in Figure 5-3, CnB binds to CnA in the presence of calcium,
activating calcineurin. At physiological levels of calcium, CnB is fully occupied
and bound to CnA. When calcium levels are elevated in the cells, CaM also binds
to CnA, dramatically inducing phosphatase activity [35].
physiological calcium
concentrations
elevated calcium
concentrations
CnA
(active calcineurin)Cn0
+ CnA
(active calcineurin)
Figure 5-3: Calcineurin regulation. CnB shows strong homology to CM; both
subunits can activate CnA. However, CM has a much lower affmity for Ca 2+ than
CnB and only interacts with CnA at elevated free calcium concentrations.
5.4.2 Manufacturing of GST-Fusion Protein Substrate
A radioactively-labeled, glutathione S-transferase (GST)-fusion protein was
manufactured to assay calcineurin activity. The pGEX2T.RII expression vector
was obtained (restriction map provided in Figure 5-4) and transformed into super-
competent XL1Blue yeast cells.
Potential transformants were selected from LB + ampicillin plates and
inoculated. Plasmid DNA was later isolated through a Wizard Miniprep and
digested with BamHI and EcoRI restriction enzymes to verify that the
transformants contained the desired expression vector and insert. As illustrated in
Figure 5-5, the DNA fragments were visualized by 0.8% agarose gel
electrophoresis and ethidium bromide (EtBr) staining. The 5 kb pGEX2T vector
was successfully located; however, the 0.05 kb RII insert was too short to be seen
(even with a subsequent 2% agarose gel). Stocks were made of confirmed
transformants and stored in glycerol at -80 oC.
Next, 1 liter of LB + ampicillin was inoculated with a transformant. At
an OD 590 reading of 0.5 (cells in S phase growth), the transformants were induced
with 150 ýpg/ml (IPTG), a gratuitous inducer of the LacZ operon. Samples were
taken before induction, at the time of induction, and every hour after induction for
5 hours. As shown in Figure 5-6, the samples were later visualized by a 12% SDS-
poly acrylamide gel electrophoresis (PAGE). After 1 hour, a 26 kDa band begins
to darken, illustrating induction of the GST-fusion protein. The cells were
incubated overnight. The GST-fusion protein is not believed to be toxic to the
cells.
EcoRI
GSLDVPIPGRFDRRVSVAAES
RII Peptide
PGEX2T.RII
not to scale
AMPr
Figure 5-4: Restriction map of pGEX2T.RII
iLacZ BamHI
Gstr
23.1 kb1 -
9.4 kb--
6.6 kb--
4.4 kb --
Figure 5-5: Agarose gel (0.8%) electrophoresis of digested plasmid DNA. DNA-
size standards were loaded in lane 1. BamHI- and EcoRI-digested plasmid DNA
was loaded in lane 2. The 4.9 kb pGEX2T vector is visualized, but the 63 base RII
insert is too short to be seen. Undigested plasmid DNA was loaded in lane 3 as a
control. Contrast and brightness of this image was digitally enhanced.
Figure 5-6: 12% SDS-poly acrylamide gel electrophoresis used to verify induction
of desired protein. Lane 1 shows proteins from transformed cells at the time of
IPTG induction. The density of a band corresponds to the concentration of the
protein (i.e. darker the band, greater the protein concentration). Lane 2 shows
proteins in transformed cells 1 hour after induction, lane 3 at 2 hours, lane 4 at
3 hours, and lane 5 at 4 hours after induction. Lanes 7, 8, 9, 10, 11 show the
concentration of proteins in XLIBlue controls at 0, 1, 2, 3, 4 hours after induction,
respectively. Molecular weight marker was loaded in lane 6. The arrow indicates
the weight of the induced protein. Contrast and brightness of this image was
digitally enhanced.
The next morning, the cells were harvested and the GST-fusion protein was
purified. At 4 °C, the cells were lysed, sonicated, and extracts run over an affinity
column composed of glutathione agarose beads. The GST portion of the protein
binds reversibly and with high affinity to the matrix allowing the desired protein to
be isolated [15].
After sufficient washing, the GST-fusion protein was phosphorylated with
radioactive 32P using protein kinase A (PKA) and y-32 P-ATP. After the column
was washed many times, the protein was eluted with 50 mM glutathione. The
purified fraction was dialyzed for 1 hour in 500 ml cold 25mM Tris pH 7.4, 5 mM
EGTA, 2mM DTT, 0.11% (w/v) Triton X-100, 50% (v/v) glycerol. Aliquots were
prepared and stored at -20 oC under proper radioactive shielding.
An aliquot was used to characterize the protein. The concentration of
protein was determined to be 341 ýgg/ml using Coomassie Brilliant Blue and a
500 p.g/ml BSA reference (Bradford method). Ten microliters of solution
produced approximately 90k counts/minute. Another 12% SDS-PAGE protein gel
was run with pre-induction lysate, post-induction/pre-purification lysate, and post-
purification lysate to visualize the effectiveness of purification. As illustrated in
Figure 5-7, the lane containing purified protein contains two bands: the desired
GST-fusion protein (GST + RII) and GST alone (degraded protein).
4:
Figure 5-7: 12% SDS-poly acrylamide gel electrophoresis used to verify
purification of desired protein. Lane 1 shows molecular weight standards. Lane 2
contains proteins from transformed cells prior to IPTG induction. Lane 3 shows
proteins 16 hours after induction. Lane 4 shows remaining proteins after
purification. The arrow indicates the weight of the purified protein. Contrast and
brightness of this image was digitally enhanced.
5.4.3 Assay
A calcineurin assay buffer containing 20 mM Tris HCI (pH 7.5), 0.1 M NaC1,
12 mM MgCl 2, 25 ptM okadaic acid was prepared. This buffer was combined with
10 mM calmodulin, 10 ptL of the radioactive substrate, and 10 units of calcineurin
(50.2 nM) and allowed to incubate at 30 oC. After 15 minutes, the solution was
stopped with an 5 ml of 30% TCA in sodium phosphate buffer with 15 mg BSA.
The mixture was centrifuged at 12,000 RPM for 10 minutes at 4 oC. 500 pL of
supernatant was extracted, and radioactivity (gamma) was measured with a
Packard Tri-Carb liquid-scintillation spetrophotometer.
5.4.4 Results
Figure 5-8 shows the result of 8 assays. The target time-averaged calcium
concentration was approximately 2.5 pM for these assays. Numerical results are
given in Table 5.3.
Table 5.3: Calcineurin assay results
Calcineurin Assays (n = 2,2,2)
I I I
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
frequency (oscillations/minute)
Figure 5-8: Calcineurin assays. Time-averaged [Ca 2+] was 5 ýpM for these runs.
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5.4.5. Analysis
The assay results suggest that calcineurin activity appears to be frequency-
independent over the range explored (Figure 5-8). Additional assays with shorter
incubation times were conducted at high frequencies up to 8 min-' (though not
physiologically observed), but assays became increasingly variable. Several
interpretations, however, can be drawn from the data:
* Calcineurin may be a fast activating, fast deactivating enzyme similar to
protein FF, modeled in section 3.
* The artificial calcium generating system is not measurably disrupting
the in vitro system since frequency and therefore the number of artificial
calcium spikes do not affect the activity of calcineurin

Chapter 6
Discussion
Calcium plays an important role in signal transduction. Calcium oscillations,
therefore, must have an influence over cellular processes. Whether the
biorhythmic phenomena is the result of a highly-evolved coding scheme or the
artifact of periodic cellular processes has yet to be established convincingly.
Important work, however, has shown that the frequency of oscillations can be
controlled by external agonists. Moreover, the mechanism that controls the rate of
oscillations is biochemical in nature [22]. Combined, these findings strengthen the
premise that calcium oscillations represent a type of frequency-encoded
information train.
Any of the various components of cellular machinery involved in Ca2+
homeostasis (such as Ca2+-receptors and Ca2+-selective ion channels) could
potentially be frequency modulated by calcium oscillations. Consider a cellular
process that is slow in tracking a calcium-high to calcium-low transition. This
slow deactivation would be exploited at higher frequencies of oscillations. For
example, a calcium spike could activate additional receptors before ligands from a
previous spike could be completely can be degraded.
Similar observations have been made in the short-term potentiation of
neurons. Multiple presynaptic spikes will elevate postsynaptic potential such that
the frequency of inputs can affective the magnitude of the output [43].
This thesis examined calcium-activated enzyme systems as a potential type
of biomolecular "decoder" of these calcium signals. Computer models of simple,
hypothetical protein systems show that they can be frequency-dependent at
physiologically-relevant conditions and at observed time-scales. Again, slow
deactivation systems were influenced by higher frequency oscillations. Repetitive
calcium peaks yielded an additive effect, elevating the observed enzyme activity.
Additional simulations showed that calcium oscillation are potentially
information-bearing. Models demonstrate that the same calcium oscillations can
influence two enzymes differently and in a manner which is biologically
meaningful. Since different enzyme systems have widely varying calcium
requirements and activation/deactivation characteristics, each protein is likely to
have an unique, activation-threshold frequency. Calcium oscillations, therefore,
represent a versatile, intracellular signal with the ability to "turn on" a particular
enzyme system without disturbing others. Furthermore, if both proteins require the
same substrate in a metabolic pathway, one end product will be favored at low
frequencies of calcium oscillations. Another end product will be favored at high
frequencies. All told, these models present an attractive frequency-domain
encoding/decoding paradigm.
Specialized equipment was designed and constructed to generate artificial,
calcium oscillations for in vitro study. The prototype used in the investigation
alternately released small volumes of calcium solution and EGTA (calcium
chelator) solution into assay buffer. Periodical delivery via miniature solenoid
valves was synchronized with a programmable microcontroller designed for this
task. Calcium concentration was continuously monitor using molecular probes and
a fluorescent instrument manufactured by Photon Technologies International (PTI)
Inc. (Princeton, NJ).
The fluorescent probe was excited with a 75-watt xenon arc lamp placed at
the focal point of a condenser to collimate the light. A rotating chopper in which
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mirror vanes alternate with transmitting sectors directed reflected light to one
monochromator and transmitted light to another monochromator. The two outputs
were combined to form a common optical path that ultimately excited the aqueous
sample contained in a cuvette.
A photo-counting photomultiplier device oriented 900 from the excitation
path was used to measure the amplitude of emission light output at a specific
wavelength. Data acquisition was performed using PTI software running on an
IBM AT/286 computer using MS-DOS operating system. Data was retained in
packed binary format and exported as ASCII files for manipulation by high-
performance numerical computation and visualization software packages.
During the testing of the equipment, tolerances for maintaining an aqueous
signal proved to be tight. A baseline of 1 pM (1 x 10-6 moles per liter) represented
a weak small signal that was easily corrupted. Many hardware/firmware
modifications were required to achieve a stable, reliable, repeatable setup. The
current implementation permits the operator to input real-time adjustments while
monitoring calcium concentration via continuous fluorescence instruments.
As this thesis is being written, a benchtop calcium oscillator is being
constructed with the experience gained. This specialized instrument will employ
optics to allow feedback control of calcium and EGTA addition. The hope of the
benchtop system is provide a useful tool to facilitate further investigation of
calcium oscillations investigation in the Bonventre laboratory.
Three calcium-activated, enzyme systems-phospholipase A2 (PLA2),
calpain type I (protease), and calcineurin (phosphatase)-were studied with the
prototype calcium oscillator. A reliable assay was established for each enzyme. In
addition, molecular biology technologies were required to manufacture a
radioactively-labeled GST-fusion protein necessary to assay calcineurin activity.
Enzymatic activities were measured both at different static calcium
concentrations and at different frequencies (ranging from 0.5 min-l to 4 minf ).
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Results were inspected as a function of mean calcium concentration (over time)
and frequency of oscillation. As discussed in the appendix, an attempt was made
to create custom analytical software to scrutinized empirical results for frequency-
dependency. For PLA2, assay results were noisy (even with static concentrations
of calcium). For calpain and calcineurin, assay results proved to be far more
consistent but still did not yielded frequency-dependency trends that could be
interpreted.
While this thesis falls short of documenting a frequency-dependent enzyme
system in vitro, progress was made in the development of an encoding/decoding
model, the design of specialized hardware for generating calcium oscillations, and
the tools necessary to analyze empirical results. These contributions offer some
thought for future work:
* Calcium-activated, slow deactivation systems need to be established and
studied in the frequency domain. The models imply that frequency-dependency
should not be observed in fast deactivation systems. Calpain and calcineurin
may represent such complexes.
* Shorter assays would allow higher frequency calcium oscillations to be
explored (where models suggest that elevated activity will be observed).
* A calcium chelator other than EGTA may need to be considered (such as
BAPTA). EGTA's extremely high affinity for calcium is much greater than
normal, cellular sequestering mechanisms [10]. Therefore, artificial chelator
could interfere with the protein activation and deactivation rates.
* The calcium-activated enzyme, Ca2 -ATPase, may represent a unique system to
consider since an artificial chelator is not necessary [3,33,38]. Ca2+-ATPase,
which controls the re-update of calcium into the sarcoplasmic reticulum (SR),
is found in cardiac cells where cytosolic calcium concentration is well known
to oscillate.
Appendix A
Analytical Software
An attempt was made to create custom analytical software to determine the ra and
'd time constants and to scrutinized empirical results for frequency-dependency.
The software's methodology may be best considered as two separate parts. In the
first part, individual assays were processed one at a time. As shown in
equation A.1, each run was initially represented by 3 independent factors: its
continuous-time fluorescence data, the measured product endpoint, and the
frequency of the run's oscillations.
run = {fluorescence(time), measured endpoint product, frequency) (A. 1)
As shown in Figure A-1, the fluorescence data was converted to a
continuous-time calcium concentration. The signal was then smoothed by a
Chebyshev lowpass filter. A first derivative of the calcium time course allowed
the rising and falling edges of the calcium peaks to be determined. Then, as
illustrated in Figure A-2, the amount of activated enzyme (i.e. the population of
enzyme activated by calcium) was estimated by superposing activation and
deactivation transients to the smoothed calcium concentration time course. These
transients represent the additional enzyme active due to slow deactivation
following a free calcium high to free calcium low transition as well as the enzyme
calcium (time)
Z&continuous-timefluorescence data, -measured activity,
and frequency of
oscillation
smoothed
calcium (time)
L r
lowpass filter
+
superposition
simulated bonded
calcium (time)
repeat with new combination
of activation and deactivation
time constants
stored in database: mean calcium,
measured activity, time constants
Figure A-i: Block diagram of analytical software
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Figure A-2: Superposition of binding and unbinding transients to smoothed
calcium concentration time course. The first plot from the top is a smoothed
calcium concentration time course, the second plot shows the amount of activated
enzyme when intracellular calcium is low due to protein deactivation, the third plot
shows the amount of enzyme not activated when intracellular calcium is high due
to protein activation, and the fourth plot shows the amount of activated enzyme, a
superposition of the top three plots. Enzyme and substrate are assumed to exist in
excess, and the time integral of activated enzyme is assumed to be linearly related
to the amount of endpoint product.
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not active due to slow activation following a free calcium low to free calcium high
transition.
In this manipulation, enzyme and substrate are assumed to exist in excess
(where calcium is the limiting factor of the reaction). While this artificial measure
does not describe the actual quantity of activated enzyme, the time integral of the
superposed time course was presumed to be linearly related to the amount of
endpoint product.
Because real time constants for the transients are not known, the process of
estimating the activated enzyme time course was repeated with Ta and td values
independently ranging from 0.1 to 2 seconds in increments of 0.1 second. As
shown in equation A.2, each run was then represented as a two-dimensional array.
Data from all runs for a particular enzyme system were stored in a database.
run(ra, d) =
(activated enzyme time integral, (A.2)
measured endpoint product,
frequency}
The second part of the analytical software attempted to select the correct
Ta and Td time constants from the 900 possible combinations previously generated.
Runs from each frequency were incorporated into a single 1/product vs.
1/avg[Ca ]bou,,d Lineweaver-Burke relationship (described in subsection 3.2.3).
The product values represented the measured endpoint product, and the
avg[Ca2]bound values were the "effective" calcium bound to calcium--directly
derived from the activated enzyme time integral. Assuming that enzyme was
completely activated by a single calcium ion (see equation 3.9), avg[Ca2+]bound
was calculated by time-averaging measured endpoint product.
As illustrated in Figure A-3, this method presupposed that, at the correct
combination of activation and deactivation time constants, the data points would fit
a straight line. Therefore, the goodness offit (the sum of differences between the
processed data and the Lineweaver-Burk fit) of all time constant combinations
were compared, and the correct t a and -cd time constants were selected from the
best fit. It should be noted that in the determination of error only 1/avg[Ca2+]bound
differences were considered (i.e. the amount of product measured from the assay
was assumed to be correct). The results are provided in Table A.1, Table A.2,
Table A.3.
In addition, 1/product vs. 1/avg[Ca2+] Lineweaver-Burke plots were
generated. Here, the avg[Ca2 +] values were obtained from the measured calcium
time course. Since this method allowed runs with varying time-averaged calcium
concentrations to be compared, additional assays could be included in the
aggregate data set. Results are also provided in Table A.1, Table A.2, Table A.3
and Figure A-4, Figure A-5, and Figure A-6.
0-+---
0 -+
1/avg[Ca 2 1]~d
Figure A-3: Correct time constants determined by goodness of fit. Each point
represents one assay. Horizontal error arrows convey that only 1/avg[Ca2+]
differences are considered in goodness of fit. Results from the enzymatic assay are
assumed to be correct.
1/product
frequency n Ta Td goodness of Vmax Km-calcium
fit
(min-1) (seconds) (seconds) (counts/min) (counts/min) (mM)
static 10 N/A N/A 106 10,000 5.8
0.3 9 0.1 0.6 167 2,500 0.9
2.0 7 0.1 0.8 172 2,000 1.2
4.0 11 0.1 0.6 215 2,500 1.1
Table A. 1: Best fit time constants and Lineweaver-Burke results (PLA2)
frequency n Ta Td goodness of Vmax Km.calcium
fit
(min"1) (seconds) (seconds) (OD/min) (OD/min) (GM)
static 4 N/A N/A .012 1.49 5.2
2 3 min. min. .011 1.52 5.4
4 3 min. min. .012 1.47 5.1
Table A.2: Best fit time constants and Lineweaver-Burke results (calpain)
frequency n Ta Td goodness of Vmax Km-calcium
fit
(min "') (seconds) (seconds) (counts/min) (counts/min) (gM)
static 3 N/A N/A 165 10,000 0.70
0.3 3 0.5 0.3 72 9,200 1.40
2 3 0.6 0.3 184 14,000 0.40
4 3 0.6 0.3 104 11,000 1.3
Table A.3: Best fit time constants and Lineweaver-Burke results(calcineurin)
2 min-1 static
x 10-3
4 min- 1
0.3 min-:
5
1/avg[Ca] [mM]^-1
Figure A-4: Best fit Lineweaver-Burke plot (PLA2). Stars (static calcium
concentration), crosses (calcium oscillation at 0.3 min-'), x-mark (2 min' ),
circles (4 minl).
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Figure A-5: Best fit Lineweaver-Burke plot (calpain).
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Figure A-6: Best fit Lineweaver-Burke plot (calcineurin). Stars (static calcium
concentration), crosses (calcium oscillation at 0.3 min"), x-mark (2 min' 1),
circles (4 min').
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After further consideration, the utility of the analytical software became
questionable. Since calcium was incorrectly assumed to be the limiting factor of
the enzymatic reaction, 1/[Ca]bound was realized to be a measure from which time
constants cannot be independently derived. The encouraging observation that ta
and td closely matched across frequencies for each enzyme was in fact an artifact
of how the amount of activated enzyme was determined. Because transients were
linearly superposed to the calcium time course, the effects of frequency were
de-parameterized. The computationally-derived time constants would therefore
have been relatively frequency independent (as observed).
Furthermore, the PLA2 and calcineurin Lineweaver-Burke plots did not
prove to be statistically significant even after incorporating additional data.
Therefore, no interpretation could be drawn from these results. The calpain
Lineweaver-Burke plot was reliable, but did not show frequency-dependency.
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